Newcastle disease virus as a vaccine vector for humans

Alexander Bukreyev, P. L. Collins

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Emerging and re-emerging infectious diseases pose a threat to individuals worldwide and necessitate the development of new vaccines and vaccine platforms. Newcastle disease virus (NDV) is an enveloped cytoplasmic RNA virus of avian origin that is highly attenuated in humans and other primates because of a strong host-range restriction. NDV infects the respiratory tract of non-human primates and appears to remain restricted to that site. As a vaccine vector, NDV induced substantial local and systemic responses against a protein expressed by a foreign gene insert and was protective against pathogen challenge. NDV is antigenically distinct from common human viruses, accommodates foreign sequences with a good degree of stability, can be readily produced in a cell line acceptable for human product development, and exhibits a low incidence of recombination. Because of its natural tropism for the respiratory tract, NDV may be particularly effective for the development of vectored vaccines against respiratory infections as well as infections that can be transmitted through the respiratory tract.

Original languageEnglish (US)
Pages (from-to)46-55
Number of pages10
JournalCurrent Opinion in Molecular Therapeutics
Volume10
Issue number1
StatePublished - Feb 2008
Externally publishedYes

Fingerprint

Newcastle disease virus
Vaccines
Respiratory System
Primates
Emerging Communicable Diseases
Respiratory Tract Diseases
Tropism
Host Specificity
RNA Viruses
Human Development
Respiratory Tract Infections
Genetic Recombination
Viruses
Cell Line
Incidence
Infection
Genes
Proteins

Keywords

  • Intranasal immunization
  • Vaccine
  • Vector
  • Virus

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Newcastle disease virus as a vaccine vector for humans. / Bukreyev, Alexander; Collins, P. L.

In: Current Opinion in Molecular Therapeutics, Vol. 10, No. 1, 02.2008, p. 46-55.

Research output: Contribution to journalArticle

@article{0df3a0e6313640dc82e31f0733702082,
title = "Newcastle disease virus as a vaccine vector for humans",
abstract = "Emerging and re-emerging infectious diseases pose a threat to individuals worldwide and necessitate the development of new vaccines and vaccine platforms. Newcastle disease virus (NDV) is an enveloped cytoplasmic RNA virus of avian origin that is highly attenuated in humans and other primates because of a strong host-range restriction. NDV infects the respiratory tract of non-human primates and appears to remain restricted to that site. As a vaccine vector, NDV induced substantial local and systemic responses against a protein expressed by a foreign gene insert and was protective against pathogen challenge. NDV is antigenically distinct from common human viruses, accommodates foreign sequences with a good degree of stability, can be readily produced in a cell line acceptable for human product development, and exhibits a low incidence of recombination. Because of its natural tropism for the respiratory tract, NDV may be particularly effective for the development of vectored vaccines against respiratory infections as well as infections that can be transmitted through the respiratory tract.",
keywords = "Intranasal immunization, Vaccine, Vector, Virus",
author = "Alexander Bukreyev and Collins, {P. L.}",
year = "2008",
month = "2",
language = "English (US)",
volume = "10",
pages = "46--55",
journal = "Current Opinion in Molecular Therapeutics",
issn = "1464-8431",
publisher = "Current Drugs Ltd.",
number = "1",

}

TY - JOUR

T1 - Newcastle disease virus as a vaccine vector for humans

AU - Bukreyev, Alexander

AU - Collins, P. L.

PY - 2008/2

Y1 - 2008/2

N2 - Emerging and re-emerging infectious diseases pose a threat to individuals worldwide and necessitate the development of new vaccines and vaccine platforms. Newcastle disease virus (NDV) is an enveloped cytoplasmic RNA virus of avian origin that is highly attenuated in humans and other primates because of a strong host-range restriction. NDV infects the respiratory tract of non-human primates and appears to remain restricted to that site. As a vaccine vector, NDV induced substantial local and systemic responses against a protein expressed by a foreign gene insert and was protective against pathogen challenge. NDV is antigenically distinct from common human viruses, accommodates foreign sequences with a good degree of stability, can be readily produced in a cell line acceptable for human product development, and exhibits a low incidence of recombination. Because of its natural tropism for the respiratory tract, NDV may be particularly effective for the development of vectored vaccines against respiratory infections as well as infections that can be transmitted through the respiratory tract.

AB - Emerging and re-emerging infectious diseases pose a threat to individuals worldwide and necessitate the development of new vaccines and vaccine platforms. Newcastle disease virus (NDV) is an enveloped cytoplasmic RNA virus of avian origin that is highly attenuated in humans and other primates because of a strong host-range restriction. NDV infects the respiratory tract of non-human primates and appears to remain restricted to that site. As a vaccine vector, NDV induced substantial local and systemic responses against a protein expressed by a foreign gene insert and was protective against pathogen challenge. NDV is antigenically distinct from common human viruses, accommodates foreign sequences with a good degree of stability, can be readily produced in a cell line acceptable for human product development, and exhibits a low incidence of recombination. Because of its natural tropism for the respiratory tract, NDV may be particularly effective for the development of vectored vaccines against respiratory infections as well as infections that can be transmitted through the respiratory tract.

KW - Intranasal immunization

KW - Vaccine

KW - Vector

KW - Virus

UR - http://www.scopus.com/inward/record.url?scp=38649139135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38649139135&partnerID=8YFLogxK

M3 - Article

C2 - 18228181

AN - SCOPUS:38649139135

VL - 10

SP - 46

EP - 55

JO - Current Opinion in Molecular Therapeutics

JF - Current Opinion in Molecular Therapeutics

SN - 1464-8431

IS - 1

ER -